日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines

二氯乙酸和PX-478在多种癌细胞系中表现出显著的协同作用。

Parczyk, Jonas; Ruhnau, Jérôme; Pelz, Carsten; Schilling, Max; Wu, Hao; Piaskowski, Nicole Nadine; Eickholt, Britta; Kühn, Hartmut; Danker, Kerstin; Klein, Andreas

Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism

基因组和代谢稳定抗肿瘤治疗 (GMSAT) 在人类乳腺癌和结肠癌细胞系中的协同作用:一种筛选协同作用的新方法

Jérôme Ruhnau, Jonas Parczyk, Kerstin Danker, Britta Eickholt, Andreas Klein

Genome reorganization in different cancer types: detection of cancer specific breakpoint regions

不同癌症类型的基因组重组:检测癌症特异性断点区域

Christoph Standfuß, Jonas Parczyk, Jerome Ruhnau, Andreas Klein

PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling

PDE5 抑制通过诱导 PKA 信号消除癌症干细胞

Saskia Klutzny, Anna Anurin, Barbara Nicke, Joseph L Regan, Martin Lange, Luise Schulze, Karsten Parczyk, Patrick Steigemann

Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death

氟奋乃静对酸性鞘磷脂酶的功能性抑制引发缺氧特异性肿瘤细胞死亡

Saskia Klutzny, Ralf Lesche, Matthias Keck, Stefan Kaulfuss, Andreas Schlicker, Sven Christian, Carolyn Sperl, Roland Neuhaus, Jeffrey Mowat, Michael Steckel, Björn Riefke, Stefan Prechtl, Karsten Parczyk, Patrick Steigemann

A novel 3D high-content assay identifies compounds that prevent fibroblast invasion into tissue surrogates

一种新型 3D 高内涵测定法可鉴定阻止成纤维细胞侵入组织替代物的化合物

Carsten Wenzel, Saskia Otto, Stefan Prechtl, Karsten Parczyk, Patrick Steigemann

3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions

3D 高内涵筛选用于鉴定靶向休眠肿瘤球体区域细胞的化合物

Carsten Wenzel, Björn Riefke, Stephan Gründemann, Alice Krebs, Sven Christian, Florian Prinz, Marc Osterland, Sven Golfier, Sebastian Räse, Nariman Ansari, Milan Esner, Marc Bickle, Francesco Pampaloni, Christian Mattheyer, Ernst H Stelzer, Karsten Parczyk, Stefan Prechtl, Patrick Steigemann

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

在一种新的模型系统中,雄激素受体拮抗剂比卡鲁胺向激动剂的转变与前列腺肿瘤进展相关。

Culig, Z; Hoffmann, J; Erdel, M; Eder, I E; Hobisch, A; Hittmair, A; Bartsch, G; Utermann, G; Schneider, M R; Parczyk, K; Klocker, H

Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas

雌二醇介导的生长刺激与异种移植雌二醇受体阳性和阴性乳腺癌中c-erbB-2蛋白表达的关系

Naundorf, H; Parczyk, K; Zschiesche, W; Reinecke, S; Büttner, B; Saul, G J; Sinn, B; Fichtner, I

The future of antihormone therapy: innovations based on an established principle

抗激素疗法的未来:基于既定原则的创新

Parczyk, K; Schneider, M R